ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Event Center

HOUSTON–(BUSINESS WIRE)–Oceaneering International, Inc. (“Oceaneering”) (NYSE:OII) will report its fourth quarter and full year 2025 financial results on WednesdayHOUSTON–(BUSINESS WIRE)–Oceaneering International, Inc. (“Oceaneering”) (NYSE:OII) will report its fourth quarter and full year 2025 financial results on Wednesday

Oceaneering Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

2026/01/22 06:16

HOUSTON–(BUSINESS WIRE)–Oceaneering International, Inc. (“Oceaneering”) (NYSE:OII) will report its fourth quarter and full year 2025 financial results on Wednesday, February 18, 2026, after the close of trading on the New York Stock Exchange. Oceaneering will host a conference call and webcast to discuss the results on Thursday, February 19, 2026 at 10:00 a.m. Central Time (11:00 a.m. Eastern Time).

The earnings release and a link to the webcast will be posted on Oceaneering’s Investor Relations website.

Oceaneering is a global technology company delivering engineered services and products and robotic solutions to the offshore energy, defense, aerospace, and manufacturing industries.

For more information on Oceaneering, please visit oceaneering.com.

Contacts

[email protected]

Hilary Frisbie

Senior Director, Investor Relations

713-329-4755

Market Opportunity

MemeCore Price(M)

$1.62869

$1.62869$1.62869

-0.20%

USD

MemeCore (M) Live Price Chart

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.